Today: 20 March 2026
Browse Category

NASDAQ:PARA 27 December 2025 - 12 January 2026

Netflix stock rises as Paramount lawsuit turns up heat on Warner deal, HSBC starts with Buy

Netflix stock rises as Paramount lawsuit turns up heat on Warner deal, HSBC starts with Buy

Netflix shares rose 0.7% to $90.07 after Paramount Skydance sued Warner Bros. Discovery, seeking more disclosure on Netflix’s $72 billion acquisition deal and hinting at a proxy fight. Paramount’s $30-per-share cash offer expires Jan. 21 unless extended. HSBC initiated Netflix coverage with a Buy rating ahead of its Jan. 20 earnings report. Warner Bros. Discovery shares fell 1.3%.
Paramount takes Netflix-Warner deal fight to Congress as takeover battle turns political

Paramount takes Netflix-Warner deal fight to Congress as takeover battle turns political

Paramount called Netflix’s proposed acquisition of Warner Bros Discovery assets “presumptively unlawful” in a filing to U.S. lawmakers, urging scrutiny. Warner’s board backs Netflix’s $82.7 billion bid, rejecting Paramount Skydance’s $108.4 billion hostile offer as too risky due to high debt. The House Judiciary antitrust subcommittee is reviewing filings ahead of a hearing on digital streaming competition. Paramount’s tender offer expires Jan. 21.
11 January 2026
Netflix stock slips as Paramount challenges Warner deal; CPI and earnings are next

Netflix stock slips as Paramount challenges Warner deal; CPI and earnings are next

Paramount Skydance reaffirmed its $108.4 billion bid for Warner Bros. Discovery, topping Netflix’s $72 billion offer. Netflix shares fell 1.2% to $89.46. Netflix co-CEO Greg Peters received 207,420 shares as performance-based stock units vested. Investors await U.S. inflation data Jan. 13 and Netflix’s fourth-quarter earnings Jan. 20.
WBD stock rises as Paramount calls Netflix deal “presumptively unlawful” and a key deadline nears

WBD stock rises as Paramount calls Netflix deal “presumptively unlawful” and a key deadline nears

Warner Bros. Discovery shares rose 2% Friday as Paramount’s legal chief urged Congress to scrutinize Netflix’s planned deal for WBD assets, calling it “presumptively unlawful.” WBD closed at $28.89, about $1 below Paramount’s $30-per-share tender offer, which expires Jan. 21. Exiting the Netflix agreement would cost WBD $4.7 billion. Both deals face likely antitrust review and possible delays of over a year.
Netflix stock slides below $90 as Goldman trims target and Warner bid fight drags on

Netflix stock slides below $90 as Goldman trims target and Warner bid fight drags on

Netflix shares dropped 2% to $88.70 Friday after Goldman Sachs cut its price target, with pressure mounting as Paramount reiterated a higher $30-per-share bid for Warner Bros. Discovery. Paramount’s offer expires Jan. 21, while Warner would owe Netflix a $2.8 billion breakup fee if it exits their deal. Investors await Netflix’s Jan. 20 earnings for clarity on financing and strategy.
Netflix stock steadies in premarket as it backs Warner Bros deal amid Paramount bid

Netflix stock steadies in premarket as it backs Warner Bros deal amid Paramount bid

Netflix shares rose 0.1% premarket after the company reaffirmed its merger deal with Warner Bros. Discovery. Warner Bros.’ board urged shareholders to reject Paramount Skydance’s revised offer, calling the Netflix agreement superior. Warner Bros. Discovery stock gained 0.3%, while Paramount Skydance slipped 1.1%. Investors await regulatory reviews and Netflix’s Jan. 20 earnings report.
Netflix stock price forecast: NFLX stuck near $90 as Warner vote backs deal and earnings loom

Netflix stock price forecast: NFLX stuck near $90 as Warner vote backs deal and earnings loom

Netflix shares slipped 0.2% to $90.50 after Warner Bros. Discovery’s board urged shareholders to reject Paramount Skydance’s bid and back Netflix’s offer. Netflix said it has filed required antitrust paperwork and is talking with U.S. and EU regulators. The company reports fourth-quarter results and its outlook on Jan. 20. NFLX trades near the bottom of its 52-week range, below key moving averages.
Netflix stock dips after Warner rejects Paramount bid, with earnings two weeks away

Netflix stock dips after Warner rejects Paramount bid, with earnings two weeks away

Netflix fell 0.3% to $90.42 after Warner Bros Discovery urged shareholders to reject Paramount Skydance’s $30-per-share bid and back Netflix’s $27.75-a-share agreement. CFRA downgraded Netflix to “Hold,” citing risks from the Warner deal, which could raise debt and face lengthy regulatory review. Warner shares rose 0.2%, Paramount Skydance dropped 0.5%. Netflix reports earnings Jan. 20.
Paramount “running out of patience” as Warner Bros Discovery nears next Netflix deal test

Paramount “running out of patience” as Warner Bros Discovery nears next Netflix deal test

Paramount Skydance extended its $30-a-share cash tender offer for Warner Bros Discovery to Jan. 21, backed by a $40.4 billion guarantee from Larry Ellison. Warner’s board is expected to meet soon to weigh the bid against an $82.7 billion cash-and-stock deal with Netflix. Warner has not changed its recommendation in favor of the Netflix offer. As of Dec. 19, 397,252 shares had been tendered.
Netflix stock today: NFLX drops nearly 3% as Warner deal drama and earnings near

Netflix stock today: NFLX drops nearly 3% as Warner deal drama and earnings near

Netflix shares closed down 3% at $90.99 Friday, underperforming the broader market as investors weighed its $82.7 billion deal to acquire Warner Bros. Discovery’s studios and streaming assets. Paramount extended its rival $30-per-share bid for Warner Bros. Discovery to Jan. 21. Netflix will report fourth-quarter results Jan. 20.
Netflix stock today holds steady as NFL Christmas game streams hit records, Warner Bros deal watched

Netflix stock today holds steady as NFL Christmas game streams hit records, Warner Bros deal watched

Netflix said its Christmas Day NFL doubleheader set new U.S. streaming records, with the Lions-Vikings game averaging 27.5 million viewers and Cowboys-Commanders 19.9 million, citing Nielsen. The stock slipped 0.02% to $93.76 in after-hours trading. Warner Bros Discovery is expected to reject Paramount Skydance’s $108.4 billion bid, leaving Netflix’s $82.7 billion offer in play, according to a source.
Netflix stock slips as Warner seen rejecting Paramount bid; what investors are watching next

Netflix stock slips as Warner seen rejecting Paramount bid; what investors are watching next

Netflix shares slipped 0.5% to $93.70 Tuesday morning as reports said Warner Bros Discovery is expected to reject Paramount Skydance’s $108.4 billion bid, keeping Netflix’s $82.7 billion deal in focus. Warner Bros Discovery shares rose 0.4%. Netflix also released a trailer for the “Stranger Things” finale, set to premiere on New Year’s Eve.
WBD stock today: Warner Bros Discovery ends flat as Netflix-Paramount battle nears Jan. 21 deadline

WBD stock today: Warner Bros Discovery ends flat as Netflix-Paramount battle nears Jan. 21 deadline

Warner Bros Discovery shares closed at $28.79, about 4% below Paramount Skydance’s $30-per-share tender offer, as the board continues to back a rival cash-and-stock deal with Netflix valuing WBD at $27.75 per share. Paramount Skydance last week amended its bid to bolster financing but kept the price unchanged. Investors are watching for new merger filings and Tuesday’s Fed minutes ahead of the Jan. 21 tender deadline.
WBD stock hovers near takeover price as Jan. 21 tender deadline nears

WBD stock hovers near takeover price as Jan. 21 tender deadline nears

Warner Bros Discovery shares rose 0.2% to $28.86 midday Monday, trading near levels implied by rival takeover bids. Paramount’s $30-per-share cash offer, backed by a $40.4 billion guarantee from Larry Ellison, faces a Jan. 21 deadline. Warner’s board has not changed its recommendation favoring a Netflix merger. The stock traded between $28.71 and $29.10 during the session.
Warner Bros Discovery stock stuck between Netflix deal value and Paramount’s $30 bid as Jan. 21 deadline nears

Warner Bros Discovery stock stuck between Netflix deal value and Paramount’s $30 bid as Jan. 21 deadline nears

Warner Bros. Discovery shares closed down 1.4% at $28.80, between Netflix’s $27.75-per-share deal value and Paramount’s $30 cash bid. Paramount extended its amended $30 tender offer to Jan. 21, 2026, and said Larry Ellison would guarantee $40.4 billion of financing. WBD’s board is reviewing the new offer but has not changed its support for the Netflix deal.
WBD stock ends lower as Netflix-Paramount takeover fight heads toward Jan. 21 tender deadline

WBD stock ends lower as Netflix-Paramount takeover fight heads toward Jan. 21 tender deadline

Warner Bros. Discovery shares closed down 1.4% at $28.80, trading between Netflix’s $27.75-per-share merger value and Paramount Skydance’s $30 all-cash tender offer. Paramount extended its offer deadline to January 21, 2026, and reported minimal shares tendered so far. WBD’s board continues to back the Netflix deal and has advised shareholders not to act on Paramount’s bid.
Warner Bros. Discovery Stock (WBD) Weekend Update: Deal-Arbitrage Tension Builds Ahead of Monday’s Open

Warner Bros. Discovery Stock (WBD) Weekend Update: Deal-Arbitrage Tension Builds Ahead of Monday’s Open

Warner Bros. Discovery shares closed at $28.80 Friday, down 1.4%, as investors weighed a $27.75-per-share Netflix takeover deal against a $30 all-cash offer from Paramount Skydance, now backed by a $40.4 billion personal guarantee from Larry Ellison. Paramount extended its tender offer to Jan. 21, 2026, with 397,252 shares tendered as of Dec. 19.
1 2 3 4 5 7

Stock Market Today

  • Regeneus Ltd (RGS.AX) Jumps 33% on Heavy Volume, Signals Short-Term Upside
    March 19, 2026, 10:42 PM EDT. Regeneus Ltd (RGS.AX) surged 33.33% to A$0.012 on March 20, 2026, driven by unusually heavy volume of 4.28 million shares, nearly seven times the average. The stock broke above its 50-day and 200-day moving averages, indicating increased short-term trader interest in this clinical-stage biotech focused on osteoarthritis and wound healing. Despite negative earnings per share and liquidity constraints, the price action reflects momentum trading in a volatile sector. Traders should watch intraday support at A$0.010 and resistance near the year high of A$0.020. With a Meyka AI rating of 64.90 (Grade B), the stock is rated HOLD amid high volatility and thin order books typical of small-cap biotechs on the Australian Securities Exchange (ASX).
Go toTop